Medical Condition News

RSS

FDA accepts BMY and AstraZeneca's dapagliflozin NDA for review

Bristol-Myers Squibb Company and AstraZeneca today announced that the U.S. Food and Drug Administration has accepted for review a New Drug Application for dapagliflozin, an investigational compound for the treatment of adults with type 2 diabetes mellitus.

9 Mar 2011

Study finds increase in oral tongue cancer incidence in young US white females

A UNC study released this week in the Journal of Clinical Oncology finds an increasing incidence of squamous cell carcinoma of the oral tongue in young white females in the United States over the last three decades.

9 Mar 2011

Jobless African-American men may face risk of depression

Jobless African-American men might be at a greater risk of suffering from depression, new research shows. More surprising, at the other end of the income spectrum, African-American men making $80,000 and upward are also among those at higher risk.

9 Mar 2011

UCLA, Fibrocell Science enter scientific collaboration to advance cell therapy

Fibrocell Science, Inc., a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications, announced today that it has entered into a scientific collaboration with University of California, Los Angeles to research the conversion of dermal fibroblasts into pure functional human cell types that may have greater regenerative capacity.

9 Mar 2011

Study: HBV infection reduces risk of liver metastasis in CRC patients

Colorectal cancer is the second leading cause of cancer-related deaths in Western countries. Metastatic liver disease more frequently develops metachronous metastasis following treatment of CRC.

9 Mar 2011

Study: Roundworm protein can suppress inflammation in patients with sepsis

Research by the University of Liverpool has found that systemic inflammation caused by sepsis can be suppressed by a protein which occurs naturally in a type of roundworm.

8 Mar 2011

Treatment with sildenafil significantly reduces RP in patients with scleroderma

Researchers in Europe reported that treatment with modified-release sildenafil significantly reduced the frequency of attacks of Raynaud's phenomenon in patients with limited cutaneous systemic sclerosis, also known as scleroderma.

8 Mar 2011

Plexxikon commences PLX3397 Phase 2 trial in patients with Hodgkin lymphoma

Plexxikon today announced that it has treated the first patient in a Phase 2 clinical trial in Hodgkin lymphoma with PLX3397. This novel agent is an oral, selective inhibitor that down-modulates two key cell types that are thought to mediate the progression of Hodgkin lymphoma tumors — macrophages and mast cells.

8 Mar 2011

Diabetes belt mapped out in the US

A government commissioned team of researchers has now identified a diabetes belt in the U.S. County-by-county mapping shows that the highest rates of diabetes cut two paths - one strung through Tennessee, Kentucky and West Virginia, and another running eastward from Louisiana through Mississippi, Alabama, Georgia and South Carolina. This belt also touches parts of North Carolina, Virginia, Florida, Texas, Arkansas, Ohio and Pennsylvania. High-diabetes pockets crop up in Oklahoma, Michigan, Arizona, the Dakotas and elsewhere. The belt includes 644 counties in 15 states with the highest diabetes rates.

8 Mar 2011

Recent rituximab trial with TNF inhibitors reports no new safety risks in patients with RA

A recent trial of rituximab in combination with a tumor necrosis factor inhibitor and methotrexate in patients with active rheumatoid arthritis found the safety profile to be consistent with other RA trials with TNF inhibitors.

8 Mar 2011

Compugen reports positive results from CGEN-25068 in animal model to treat certain disease conditions

Compugen Ltd. announced today positive animal model results for CGEN-25068, a novel peptide predicted and selected in silico to block a specific protein-protein interaction known to play an important role in various immune-related disease conditions.

8 Mar 2011

Vertos reports long-term safety and efficacy of mild in patients with LSS

Medical device company Vertos Medical Inc. has announced the release of clinical study data demonstrating the long-term safety and efficacy of mild as well as its superior durability over epidural steroid injections for treating lumbar spinal stenosis.

8 Mar 2011

Neoprobe reports positive feedback from FDA for RIGScan development

Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, today announced that it has completed a successful pre-IND meeting with the U.S. Food and Drug Administration on the development of RIGScan CR, the Company's proprietary radiopharmaceutical for the detection of colorectal cancer tumors.

8 Mar 2011

GTHP provides update on FDA PMA review for LightTouch non-invasive cervical cancer test

Guided Therapeutics, Inc., today provided an update on the U.S. Food and Drug Administration review process for its premarket approval application for the LightTouch non-invasive test for the early detection of cervical pre-cancer.

8 Mar 2011

University of California, Irvine purchase SpineAssist to conduct minimal invasive surgeries

Mazor Robotics Ltd., a developer of innovative surgical robots and complementary products, announced today that the University of California, Irvine Medical Center has purchased SpineAssist, Mazor Robotics' surgical robotic system that enables surgeons to conduct minimally invasive and complex spine surgeries in a safe and accurate manner.

8 Mar 2011

BrainScope announces launch of Ahead EU-100 to help in head injury assessment

BrainScope Company, Inc. announced today that it is preparing for the introduction of the Ahead™ EU-100, a product in development to aid in the assessment of head injury, in the United Kingdom.

8 Mar 2011

New review shows difficulty in delivering high-quality cancer care

A shortage of oncologists and rising costs of chemotherapy and radiation therapies and imaging tests, are making delivering quality cancer care increasingly difficult, according to a new review by researchers at RTI International and Eli Lilly and Company.

8 Mar 2011

New report highlights wide range of hazardous air pollutants emitted from power plants

The American Lung Association today released Toxic Air: The Case for Cleaning Up Coal-fired Power Plants, a new report that documents the range of hazardous air pollutants emitted from power plants and the urgent need to clean them up to protect public health.

8 Mar 2011

Society of Surgical Oncology to present James Ewing Layman's award to Kimberly Duchossois

At its annual cancer symposium, the Society of Surgical Oncology will present the 43rd annual James Ewing Layman's Award to Kimberly T. Duchossois of Barrington Hills, Ill., for her deep commitment and long-term efforts to improve the quality of cancer treatment and help cancer patients get the information they need to make wise decisions about their care.

8 Mar 2011

Researchers elucidate how sensory, motor fibers interact at molecular level to form nerves

During embryonic development, sensory and motor fibers interact to form nerves in the limbs. The research team led by Dr. Andrea Huber Br-samle of the Institute of Developmental Genetics of Helmholtz Zentrum M-nchen has now elucidated how this interaction functions at the molecular level: The cell surface receptor neuropilin-1 is present in both sensory and motor nerve fibers and controls their interaction in order to correctly regulate growth.

8 Mar 2011

Medical Condition News

FDA accepts BMY and AstraZeneca's dapagliflozin NDA for review

Study finds increase in oral tongue cancer incidence in young US white females

Jobless African-American men may face risk of depression

UCLA, Fibrocell Science enter scientific collaboration to advance cell therapy

Study: HBV infection reduces risk of liver metastasis in CRC patients

Study: Roundworm protein can suppress inflammation in patients with sepsis

Treatment with sildenafil significantly reduces RP in patients with scleroderma

Plexxikon commences PLX3397 Phase 2 trial in patients with Hodgkin lymphoma

Diabetes belt mapped out in the US

Recent rituximab trial with TNF inhibitors reports no new safety risks in patients with RA

Compugen reports positive results from CGEN-25068 in animal model to treat certain disease conditions

Vertos reports long-term safety and efficacy of mild in patients with LSS

Neoprobe reports positive feedback from FDA for RIGScan development

GTHP provides update on FDA PMA review for LightTouch non-invasive cervical cancer test

University of California, Irvine purchase SpineAssist to conduct minimal invasive surgeries

BrainScope announces launch of Ahead EU-100 to help in head injury assessment

New review shows difficulty in delivering high-quality cancer care

New report highlights wide range of hazardous air pollutants emitted from power plants

Society of Surgical Oncology to present James Ewing Layman's award to Kimberly Duchossois

Researchers elucidate how sensory, motor fibers interact at molecular level to form nerves

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News